Skip to main content
OpenTrials

Clinical trial condition

Blood Protein Disorders

Explore clinical trials studying Blood Protein Disorders. Study availability and eligibility vary by location and protocol.

3,046 public trials 569 recruiting studies
Refine in advanced search Browse all conditions

Blood Protein Disorders trial results

Completed

A Phase 1/2a Dose-Finding Study of PT-112 in Patients With Relapsed or Refractory Multiple Myeloma

NCT03288480

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Mayo Clinic Cancer Center Phoenix, Arizona, United States
  • Rocky Mountain Cancer Centers Denver, Colorado, United States
  • Mayo Clinic Cancer Center Jacksonville, Florida, United States
  • Mayo Clinic Cancer Center Rochester, Minnesota, United States
View Trial Details
Completed

A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Isatuximab in Patients With Multiple Myeloma

NCT02514668

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Investigational Site Number 840003 Scottsdale, Arizona, United States
  • Investigational Site Number 840004 San Francisco, California, United States
  • Investigational Site Number 840011 Detroit, Michigan, United States
  • Investigational Site Number 840015 St Louis, Missouri, United States
View all 18 locations
View Trial Details
Completed

Collect and Assess Tissue Samples From Subjects With Hematologic Malignancy

NCT04014764

Conditions
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Blood Protein Disorders, +31 more
Locations
  • CBCC Global Research Bakersfield, California, United States
  • Pacific Central Coast Health Centers -- SLO Oncology and Hematology Health Center San Luis Obispo, California, United States
  • Colorado West Healthcare System, dba Grand Valley Oncology Grand Junction, Colorado, United States
  • Ocala Oncology Center Ocala, Florida, United States
View all 20 locations
View Trial Details
Completed

MEDI2228 in Subjects With Relapsed/Refractory Multiple Myeloma

NCT03489525

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site Jacksonville, Florida, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site Boston, Massachusetts, United States
View Trial Details
Completed

Study to Evaluate the Safety and Efficacy of Anti-CD38 CAR-T in Relapsed or Refractory Multiple Myeloma Patients

NCT03464916

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations
  • Mayo Clinic Florida Jacksonville, Florida, United States
  • Mayo Clinic Minnesota Rochester, Minnesota, United States
  • Icahn School of Medicine New York, United States
  • University of Pennsylvania, Abramson Cancer Center Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions